Rare diseases
Investigational molecules
Locations
290 conditions with trials, the busiest first
1 641 trials across Europe, recruiting first
Study on Long-Term Safety and Efficacy of Tildrakizumab for Adults with Psoriatic Arthritis
CzechiaStudy on the Safety and Effectiveness of CGT9486 for Patients with Nonadvanced Systemic Mastocytosis
AustriaStudy on the Effectiveness and Safety of HRO350 for Patients with Mild-to-Moderate Psoriasis
FinlandStudy Comparing Rituximab and Ocrelizumab for Patients with Relapsing Multiple Sclerosis Starting Anti-CD20 Therapy
The NetherlandsStudy on the Use of Hyperpolarized Xenon (129Xe) and Gadobutrol for Imaging in Patients with Progressive Fibrosing Interstitial Lung Diseases
DenmarkStudy on Imlifidase and Drug Combination for Treating Severe Goodpasture Disease in Patients
AustriaStudy on the Effectiveness of Rilpivirine-Based Treatment for HIV Patients with Metabolic Liver Disease Using Dolutegravir, Rilpivirine, and Emtricitabine/Tenofovir Combination
SpainStudy on Glucagon and Insulin for Improving Insulin Absorption in Patients with Type 1 Diabetes
NorwayStudy Comparing Bictegravir and Lenacapavir to Current Treatment in Patients with HIV-1 on Complex Regimens
FranceStudy on Long-term Safety of Ustekinumab for Children with Crohn's Disease, Juvenile Psoriatic Arthritis, or Ulcerative Colitis
BelgiumStudy on the Effects of Obexelimab for Patients with IgG4-Related Disease
FranceStudy on the Effectiveness and Safety of Benralizumab for Children with Severe Eosinophilic Asthma
FranceThe therapies tested most often in Immune system disorders trials.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
